The major U.S. benchmarks ended mostly in the red on Wednesday following Apple’s dismal fiscal fourth quarter earnings results. Apple notched its biggest daily percentage loss since Sept. 9. However, strong gains in Boeing helped the Dow to end in the green, offsetting Apple’s decline. Among the top ETFs, investors saw SPY nearly gain 0.2%, DIA rise nearly 0.3% and QQQ fall about 0.7% on the day.
Two more specialized ETFs are worth noting in particular though as both saw trading volume that was far outside of normal. In fact, in the most recent trading session, both these funds experienced volume levels that were more than double their average. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra interest continues:
PSCH: Volume 3.28 times average
This small cap healthcare ETF tracking the S&P SmallCap 600 Capped Health Care Index was in focus yesterday as roughly 41,596 shares moved hands compared with an average of roughly 13,270 shares. PSCH declined over 1.9% on the day.
Decline in shares of Edwards Lifesciences, which was the biggest loser among the S&P 500 companies, following its mixed third quarter earnings performance, had a negative impact on the healthcare sector, which in turn led to the decline in this ETF. Shares of Edwards Lifesciences plunged 17.1% after its earnings came in line with estimates and missed the same on revenues. In the last one-month period, PSCH was down 7.9%.
FKU: Volume 4.75 times average
This UK ETF was under the microscope on Wednesday as nearly 59,083 shares moved hands. This compares to an average trading volume of 13,260 shares and came as FKU lost 0.8% in the session.
Decline in bank and mining stocks following disappointing earnings performances led UK stocks to end in the red yesterday. This in turn had a negative impact on this ETF that comprises companies based in UK. In the last one-month period, FKU lost nearly 6.8%.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
The major U.S. benchmarks ended mostly in the red on Wednesday following Apple’s dismal fiscal fourth quarter earnings results. Apple notched its biggest daily percentage loss since Sept. 9. However, strong gains in Boeing helped the Dow to end in the green, offsetting Apple’s decline. Among the top ETFs, investors saw SPY nearly gain 0.2%, DIA rise nearly 0.3% and QQQ fall about 0.7% on the day.
Two more specialized ETFs are worth noting in particular though as both saw trading volume that was far outside of normal. In fact, in the most recent trading session, both these funds experienced volume levels that were more than double their average. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra interest continues:
PSCH: Volume 3.28 times average
This small cap healthcare ETF tracking the S&P SmallCap 600 Capped Health Care Index was in focus yesterday as roughly 41,596 shares moved hands compared with an average of roughly 13,270 shares. PSCH declined over 1.9% on the day.
Decline in shares of Edwards Lifesciences, which was the biggest loser among the S&P 500 companies, following its mixed third quarter earnings performance, had a negative impact on the healthcare sector, which in turn led to the decline in this ETF. Shares of Edwards Lifesciences plunged 17.1% after its earnings came in line with estimates and missed the same on revenues. In the last one-month period, PSCH was down 7.9%.
FKU: Volume 4.75 times average
This UK ETF was under the microscope on Wednesday as nearly 59,083 shares moved hands. This compares to an average trading volume of 13,260 shares and came as FKU lost 0.8% in the session.
Decline in bank and mining stocks following disappointing earnings performances led UK stocks to end in the red yesterday. This in turn had a negative impact on this ETF that comprises companies based in UK. In the last one-month period, FKU lost nearly 6.8%.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on QQQ - FREE
Get the latest research report on SPY - FREE
Get the latest research report on DIA - FREE
Get the latest research report on FKU - FREE
Get the latest research report on PSCH - FREE